skip to main content

H.R. 2212 (115th): CREATES Act of 2017

Call or Write Congress

React to this bill with an emoji

(About Ads | Hide These Ads)

To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.

The bill’s titles are written by its sponsor.

Sponsor and status

Photo of sponsor Tom Marino

Tom Marino

Sponsor. Representative for Pennsylvania's 10th congressional district. Republican.

Thumbnail of bill text
Read Text »
Last Updated: Apr 27, 2017
Length: 20 pages
Introduced
Apr 27, 2017
115th Congress (2017–2019)
Status
Died in a previous Congress

This bill was introduced on April 27, 2017, in a previous session of Congress, but it did not receive a vote.

Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).

Cosponsors

25 Cosponsors (13 Democrats, 12 Republicans)

Source
Congress.gov

Position statements

What legislators are saying

“Congressman Marino to Hold Hearing on Drug Competition and Pricing with FDA Commissioner Gottlieb”
    — Rep. Tom Marino [R-PA12, 2019-2019] (Sponsor) on Jul 26, 2017

“Congressman Francis Rooneys statement on the Presidents plan to lower drug prices”
    — Rep. Francis Rooney [R-FL19, 2017-2020] (Co-sponsor) on May 14, 2018

“Culberson Applauds Legislation to Save Patients Money on Prescription Drugs”
    — Rep. John Culberson [R-TX7, 2001-2018] (Co-sponsor) on Oct 15, 2018

More statements at ProPublica Represent...

What stakeholders are saying

Coalition to Reduce Spending The Coalition to Reduce Spending supports the passage of the CREATES Act as a market-based solution that allows manufacturers the ability to purchase the samples they need to bring more affordable FDA-approved drugs to market. Public estimates are that CREATES would …

History

Apr 27, 2017
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

H.R. 2212 (115th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 2212. This is the one from the 115th Congress.

This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2212 — 115th Congress: CREATES Act of 2017.” www.GovTrack.us. 2017. March 26, 2023 <https://www.govtrack.us/congress/bills/115/hr2212>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.